SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Infectious Diseases Consultation — Florence Nightingale

PatientFlorence Nightingale
Date of birth1988-05-12
IdentifiersMRN HR-NI004-SYN; SSN (made up) 000-04-9271
Document date2026-03-16
AuthorDaniel Abernathy, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Suspected post-infectious ME/CFS in a 37-year-old nurse administrator who was treated for brucellosis abroad. Before we attribute her symptoms to ME/CFS, please assess for relapsed or focal brucellosis or another persisting infection. [S]

Urgency: Routine, within two weeks. [S]

Questions for the consultant:

History of Present Illness

Ms. Nightingale is seen at the request of Dr. Marchetti. Nearly three years ago, on an overseas field-hospital deployment, she had several weeks of high fever, drenching sweats, and generalized aches; a Brucella agglutination titer was reported positive, and she completed six weeks of doxycycline with rifampin. The fever never returned. She has had no night sweats, weight loss, localized back or hip pain, or joint swelling since, and no unpasteurized dairy since returning. What persists is fatigue worsened by activity with delayed post-exertional malaise, unrefreshing sleep, cognitive difficulty, and lightheadedness on standing. Occupational tuberculosis screening on her return was negative, and she reports no needle-stick injuries. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a dayOne to two tablets by mouth every 6 hours as needed; no more than 3 g a dayOral route2025-11-03activeS
Cholecalciferol (vitamin D3) 50 mcg (2,000 units) oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-03-16activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFSactiveconfirmed G93.32S — Synthetic diagnosis made by clinical criteria after exclusion tests in the modern episode; the historical reading of her illness as ME/CFS remains R and disputed.
Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapseactiveconfirmed Z86.19S — Synthetic history echoing the disputed retrospective interpretation of her Crimean fever as brucellosis; not a historical diagnosis.
Vitamin D deficiencyactiveconfirmed E55.9S — Synthetic finding on the intake tests, reviewed at the two-week visit.

Physical Exam

Vital signs recorded on 2026-03-16; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralAlert, articulate, afebrile; prefers to sit reclined
Lymph nodesNo lymphadenopathy
HeartRegular rhythm; no murmur
AbdomenNo liver or spleen enlargement
MusculoskeletalNo spinal percussion tenderness; sacroiliac stress tests negative; no joint swelling or synovitis

Assessment

Data reviewed: The intake exclusion tests reviewed this morning: normal blood count, metabolic panel, liver tests, ESR 8 mm/h, CRP 1.2 mg/L, creatine kinase, and morning cortisol; 25-hydroxyvitamin D low at 17 ng/mL. The intake standing test. The report of the positive Brucella titer and the treatment record from abroad. [S]

Plan of Treatment